The capability gap is real
Large manufacturers have regulatory, quality, clinical, security and legal functions. Startups often have the same obligations long before they have that structure.
The answer is not to copy the corporate machine. The answer is to bring in the right capability at the right moment and keep it coordinated through one accountable plan.
The early decision matters
Most regulatory delays begin before the formal assessment. They start when the product, claims, users and evidence expectations are not aligned early enough.
For a startup or scale-up, the goal is not to build every possible compliance artefact immediately. The goal is to know which decisions unblock credible market access and which work can mature later.
What Neural Vibe orchestrates
Neural Vibe combines founder-led regulatory judgment, AI-enabled delivery workflows and a trusted specialist network.
That gives clients a route-to-market workstream without asking the leadership team to become full-time compliance coordinators.
The early-stage company has mature obligations before it has mature infrastructure
Health-tech founders often face an uncomfortable mismatch. The company may still be small, but the obligations around safety, evidence, data, software quality and market access are serious. Waiting until there is a full internal team can delay the product; pretending the obligations are lighter can damage trust.
The practical answer is a capability model that scales. Bring in senior judgement early, add specialist depth when the project requires it and keep the operating burden proportionate to the stage of the company.
Do not copy the corporate machine
Large manufacturers have committees, departments and legacy processes because they manage large portfolios and established markets. A startup needs the same quality of thinking, but not the same weight of infrastructure. Copying the machine too early creates noise, cost and resistance.
A better model is decision-centred. What must be decided now? What evidence unlocks the next market step? What risks need control before launch? What can mature later without creating rework? This keeps compliance connected to commercial progress.
AI-enabled delivery changes the economics
AI agents can accelerate research, mapping, drafting, comparison and evidence organisation. That does not remove the need for human judgement. It changes where human judgement is best used: shaping the route, reviewing the logic, challenging assumptions and deciding what matters.
For Neural Vibe, AI-enabled delivery is not a gimmick. It is a way to give smaller teams access to a level of pace and structure that would otherwise require more headcount.
Specialists should be orchestrated, not dumped on the client
Regulated health technology often needs specialist input: clinical safety, cybersecurity, information governance, FDA strategy, international representation, legal review or notified body experience. The problem is that clients are often left to coordinate those experts themselves.
Neural Vibe’s model is to act as the accountable orchestrator. The client has one plan, one route-to-market story and one partner responsible for keeping the work coherent, even when deeper specialists are brought in.